THE THROGMORTON TRUST PLC
All information is at 31 December 2010 and unaudited.
Performance at month end is calculated on a cum income basis
One Three One Three
Month Months Year Years
Net asset value# 11.3% 19.9% 64.4% 44.4%
Net asset value^ 11.3% 19.9% 64.4% 38.0%
Net asset value^^ 9.8% 17.7% 53.4% 28.4%
Share price 14.1% 22.8% 61.8% 41.2%
Subscription share price 69.1% 203.7% n/a n/a
HGSC plus AIM (ex Inv Cos) 9.4% 13.1% 31.5% 11.1%
# NAV prior to costs of repaying the debentures early
^ NAV after costs of repaying the debentures early - undiluted
^^ NAV after costs of repaying debentures early - diluted
Sources: BlackRock and Datastream
At month end
Net asset value capital only: 234.27p
Net asset value incl. income: 236.95p
Share price: 186.00p
Discount to capital only NAV: 20.6%
Subscription share price: 41.00p
Net yield: 1.5% *
Total assets: £151.4m **
Gearing: nil
Ordinary shares in issue: 59,819,714 ***
Subscription shares in issue: 13,310,612
*Calculated using prior year interim and final dividends paid.
**Includes current year revenue.
***Excluding 7,400,000 shares held in treasury.
Ten Largest Sector
Weightings % of Total Assets
Software & Computer Services 9.8
Electronic & Electrical Equipment 9.3
Oil & Gas Producers 9.2
Support Services 8.6
Mining 8.2
Financial Services 7.0
Industrial Engineering 6.5
Media 4.7
Pharmaceutical & Biotechnology 4.5
Technology Hardware & Equipment 4.0
----
Total 71.8
====
Ten Largest Equity Investments (in alphabetical order)~
Company
Abcam
Aveva Group
City of London Investment Group
Domino Printing Sciences
Fidessa
Hutchison China Meditech
IQE
ITE Group
Oxford Instruments
Spirax-Sarco Engineering
Commenting on the markets, Mike Prentis and Richard Plackett, representing the
Investment Manager noted:
December was a strong month for equities generally and also for the Company.
The Company's NAV per share rose by 11.3% on a cum income basis, whilst the
benchmark index increased by 9.4%. The FTSE 100 Index rose by 6.7%.
The main positive contributor to our outperformance in the month, relative to
the Company's benchmark, was our holding in ITE Group, which organises
exhibitions. ITE announced final results and gave a positive outlook on its key
markets. Russia is ITE's key geographical market and has been impacted by
severe recession over the last few years. Management talked of strengthening
recovery in Russia and also stable or improving conditions in their other
markets of Turkey, India and the UK.
There was no significant negative contributor to relative performance during
the month, in that no one holding detracted from relative performance by more
than 0.25%.
The CFD portfolio achieved a strong gain during the month. This was due to the
performance of our long CFDs, partly offset by some loss of value in our short
CFDs.
We sold the balance of our holding in Western Coal following the bid. We added
new holdings in Howden Joinery and Vectura, each 0.5% of net assets. Howden
manufacture and sell fitted kitchens in the UK; its customers are local
builders who fit the kitchens. We regard the management highly and see this as
a key provider in the UK, good exposure to the consumer, where we are
underweight, and at an attractive valuation. Vectura develops inhaled therapies
for respiratory diseases. It has an interesting portfolio of late stage
development products and we see 2011 as the year when the Company could make
significant progress. As with Howden, we regard management highly.
21 January 2011
ENDS
Latest information is available by typing www.blackrock.co.uk/its on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.